Sharemaestro Newsreel

AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis

A Pennsylvania man has filed a lawsuit against AngioDynamics and Navilyst Medical, alleging that a defective SmartPort catheter caused a severe infection and sepsis, necessitating its surgical removal. The complaint claims that defects in the port catheter promoted bacterial growth and that the companies …

Embecta Corp. (Nasdaq: EMBC) Q3 2026 revenue dips as earnings outlook raised

Sarasin & Partners LLP Grows Holdings in Intuitive Surgical, Inc. $ISRG

Sarasin & Partners LLP significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 128.2% in the second quarter, now owning 244,426 shares valued at $97.2 million. This comes as Intuitive Surgical reported stronger-than-expected quarterly results, with EPS of $2.80 and revenue of $2.89 …

Merit Medical Systems Chief Operating Officer Neil Peterson Sells 68% Of Holding

Merit Medical Systems' Chief Operating Officer, Neil Peterson, recently sold 68% of his holdings, netting US$1.8m. This significant sale, along with other insider selling activities totaling US$7.3m over the last year, raises some concerns despite the company's profitability and strong insider ownership. While high …

PensionDanmark Pensionsforsikringsaktieselskab Has $26.73 Million Position in Intuitive Surgical, Inc. $ISRG

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Intuitive Surgical, Inc. by 15.9% in the second quarter, bringing its total holdings to 67,208 shares valued at $26.73 million. Intuitive Surgical reported strong quarterly earnings, beating analyst estimates with $2.80 EPS and $2.89 billion in revenue, an …

Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Microbot Medical Inc (MBOT) has an earnings forecast score of 8.00, placing it 169th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $8.75 for MBOT, with a high of $12.00 and a low of $5.50. Based on …

embecta Sets Sept. 15 Payment Date for $0.01 Cash Dividend

embecta (Nasdaq: EMBC) has announced that its Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend is payable on September 15, 2026, to stockholders of record as of August 27, 2026. Following this news, EMBC's stock gained 27.29%, indicating …

embecta Announces Quarterly Cash Dividend

Embecta Corp. (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 per share. The dividend is payable on September 15, 2026, to stockholders of record as of August 27, 2026. Embecta is a global medical supplies company focused on insulin delivery and other …

ResMed’s Q4 Earnings Beat Street Estimates, But FY27 Guidance Hides the Real Growth Rate.

ResMed (RMD) exceeded Q4 revenue and EPS estimates but its FY27 guidance of 5%-7% core revenue growth and $12-$12.25 non-GAAP EPS understates its true growth potential. The guidance is significantly impacted by a $75 million Astral ventilator field safety action, which will halt new …

Solventum Corp (SOLV) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cooper Companies Inc (COO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cooper Companies Inc (COO), focusing on its current price momentum, support and resistance levels, and various technical indicators and moving averages. It highlights that COO's stock is trading between a resistance level of 76.18 and a support …

Becton, Dickinson and Company Stock 12‑Month Price Target Raised to $187.18, Implies 10% Upside

Becton, Dickinson and Company's (BDX) average 12-month price target has been increased to $187.18 by 11 analysts, up from $178.2, implying a 10% potential upside from its Aug. 5 closing price. The consensus rating for the stock remains a "Buy" among 16 analysts, with …

OraSure Technologies Inc (OSUR) Stock News Today

Intuitive Surgical’s Dave Rosa on robotic surgery’s next era

This article features Intuitive Surgical CEO Dave Rosa discussing the future of robotic surgery. It highlights the company's role in advancing medical technology and briefly mentions other medical device news and political topics in the healthcare sector.

WRBY Q2 Deep Dive: Intelligent Eyewear Launch and Traffic Softness Shape Outlook

WRBY Q2 Deep Dive: Intelligent Eyewear Launch and Traffic Softness Shape Outlook Eyewear retailer Warby Parker (NYSE:WRBY) fell short of the market's revenue expectations in Q2 CY2026, but sales rose 9.8% year on year to $235.5 million. The company's full-year revenue guidance of $967.5 …

Analysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST)

Barclays analysts have offered varied ratings for several healthcare companies. Etzer Darout maintained a Buy rating for Protagonist Therapeutics (PTGX) with a $153.00 price target, while Luke Sergott gave Qiagen (QGEN) a Hold rating with a $38.00 target. Glen Santangelo maintained a Buy rating …

Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS

Royal Bank of Canada increased its stake in BioLife Solutions (NASDAQ:BLFS) by 8.1%, purchasing an additional 66,010 shares, bringing its total to 885,298 shares valued at approximately $16.9 million. This transaction comes as other institutional investors have adjusted their positions, and despite a major …

BLFS Looks 16.4% Overvalued on GF Value™ Amid Strong Q2 Revenue Beat

Pro-Dex Inc (PDEX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Amundi Has $4.62 Million Stake in Teleflex Incorporated $TFX

Amundi increased its stake in Teleflex Incorporated (NYSE:TFX) by 325.2% in the first quarter, now holding 38,606 shares valued at approximately $4.62 million. Teleflex exceeded second-quarter expectations with adjusted EPS of $1.76 and revenue of $570.3 million, and raised its fiscal 2026 EPS guidance …

Becton Dickinson raises lower end of annual profit forecast on drug delivery devices strength

Becton Dickinson raised the lower end of its annual adjusted profit forecast for 2026 after exceeding Wall Street estimates for its third-quarter profit and revenue. The company attributed this performance to strong demand for its drug-delivery devices and surgical equipment. Despite potential cost increases …

Piper Sandler Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $6

Piper Sandler has reiterated its Buy rating for Nyxoah SA (NYXH.US) but has adjusted its price target downward from $12 to $6. This adjustment reflects a revised valuation while maintaining a positive outlook on the company's stock.

Nyxoah SA Stock 12‑Month Price Target Cut to $6, Implies 326% Upside

Nyxoah SA (NYXH) has seen its 12-month average price target reduced from $7.32 to $6 by 8 analysts, yet this new target still suggests a significant 326% potential upside based on its closing price on August 5th. Despite the cut, the consensus rating from …

Pulse Biosciences enters $75 million equity distribution agreement with Mizuho

Pulse Biosciences has entered into an equity distribution agreement with Mizuho Securities USA LLC, allowing it to offer and sell up to $75 million in common stock. Mizuho will act as the sales agent, receiving a commission of up to 3.0% on shares sold. …

Bausch + Lomb Corporation (BLCO.TO) Stock Price, News, Quote & History

This article provides comprehensive financial information for Bausch + Lomb Corporation (BLCO.TO), including its stock price, news, quotes, and historical data. It details the company's segments (Vision Care, Pharmaceuticals, and Surgical), recent earnings reports, and analyst ratings, highlighting a recent increase in revenue guidance …

Solventum (SOLV) Stock Retreats As Tariff Refund Clouds Underlying Growth

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million

Femasys Inc. announced a $30 million private placement led by Nantahala Capital, involving the sale of common stock and pre-funded warrants along with accompanying warrants. The financing could yield up to an additional $60 million if all warrants are exercised for cash, with some …

1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Earnings trigger and recent business updates DENTSPLY SIRONA (XRAY) is in focus after reporting second quarter 2026 earnings on 6 August, alongside reaffirmed full year …

Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea

This Contact Lens Stock Looks Ready to Rally

The article suggests that Cooper Cos., a contact lens manufacturer, is poised for a rally, potentially driven by the sale of a surgical unit and activist investor involvement. The long-term demand for contact lenses is projected to increase significantly due to a rise in …

FMR LLC reports 5.0% ownership of West Pharmaceutical (WST) common stock

FMR LLC has disclosed a 5.0% beneficial ownership stake in West Pharmaceutical (WST) common stock, totaling 3,559,015.80 shares as of June 30, 2026. The filing indicates FMR LLC holds sole dispositive power over these shares and sole voting power over a slightly smaller portion. …

L1 Capital Pty Ltd Sells 480,608 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock

L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global (NASDAQ:AVR) stock for approximately $3.99 million on August 4th, reducing its direct ownership by 7.87% to 5.63 million shares. This sale is part of a series of transactions by L1 Capital Pty Ltd …

KORU Medical Systems (KRMD) Stock Price Sinks After Guidance Cut Despite Profit

KORU Medical Systems (KRMD) saw its stock price drop 13.8% despite reporting a small profit and record Q2 revenue of US$12.0m. The market reacted negatively to the company's trimmed full-year revenue guidance and concerns about the timing of growth and execution risks. While the …

ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ResMed Inc. reported strong Q4 FY2026 results with a 9% headline revenue growth and a 16% increase in non-GAAP EPS, achieving 10% revenue growth and $1.6 billion in free cash flow for the full fiscal year. The company plans to return over $1.85 billion …

Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...

Nephros Inc (NEPH) reported record quarterly revenue of $6 million in Q2 2026, a 36% year-over-year increase, along with a significant surge in net income (over 400%) and Adjusted EBITDA (260%). The growth was attributed to broad-based improvements across product and service revenues, and …

BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing